KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) Cash & Current Investments (2016 - 2026)

Bausch Health Companies' Cash & Current Investments history spans 18 years, with the latest figure at $1.3 billion for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 13.4% to $1.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 13.4% increase, with the full-year FY2025 number at $1.3 billion, up 10.32% from a year prior.
  • Cash & Current Investments hit $1.3 billion in Q1 2026 for Bausch Health Companies, down from $1.3 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for BHC hit a ceiling of $2.5 billion in Q1 2022 and a floor of $497.0 million in Q3 2022.
  • Historically, Cash & Current Investments has averaged $1.1 billion across 5 years, with a median of $962.0 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: crashed 78.41% in 2023 and later skyrocketed 179.78% in 2025.
  • Tracing BHC's Cash & Current Investments over 5 years: stood at $591.0 million in 2022, then surged by 62.77% to $962.0 million in 2023, then rose by 24.84% to $1.2 billion in 2024, then increased by 10.32% to $1.3 billion in 2025, then decreased by 0.98% to $1.3 billion in 2026.
  • Business Quant data shows Cash & Current Investments for BHC at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.